Neonatal diabetes mellitus due to a novel variant in the <i>INS</i> gene.

Although adverse effects with adjunctive SU therapy have not been commonly described, and although there may be significant genetic and clinical differences between patients with transient or permanent NDM, we feel that whenever possible it is important to prioritize ancillary genetic testing that may substantially impact management.

also in 13,097 other papers